“We had an idea at an early stage, but we needed support to make those ideas into actual experimental data,” Dr. Olsen says. “In research, novel ideas are most important, but at the same time, it’s difficult to get new ideas tested. This was the starting money for this new line of thinking.”
While the focus of the initial study is on methotrexate, Dr. Olsen says her research also offers insight into RA and may lead to new treatments for the disease, or information to make existing treatments more effective.
For more information about the Foundation’s Awards and Grants program, including how to apply, visit www.rheumatology.org/Foundation or contact the Foundation’s Damian Smalls, senior specialist for awards and grants, at (404) 633-3777 or [email protected].
